New Delhi [India], May 15 (ANI-BusinessWireIndia): Pfizer announced that its 13-valent Pneumococcal Conjugate Vaccine has been selected for inclusion in India's immunization program in select states. In the first phase, the program will cover approximately 5.15 million babies - 20 perce